Sensitizing Ewing sarcoma to chemo- and radiotherapy by inhibition of the DNA-repair enzymes DNA protein kinase (DNA-PK) and poly-ADP-ribose polymerase (PARP) 1/2

BACKGROUND: DNA-PK and PARP inhibitors sensitize cancer cells to chemo- and radiotherapy. ETS transcription factors (EWS-FLI1) have been described as biomarkers for PARP-inhibitor sensitivity. Sensitivity to single agent PARP inhibitors has so far been limited to homologous recombination repair (HRR...

Descripción completa

Detalles Bibliográficos
Autores principales: Vormoor, Britta, Schlosser, Yvonne T., Blair, Helen, Sharma, Abhishek, Wilkinson, Sarah, Newell, David R., Curtin, Nicola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768336/
https://www.ncbi.nlm.nih.gov/pubmed/29371919
http://dx.doi.org/10.18632/oncotarget.21300

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5768336/
https://www.ncbi.nlm.nih.gov/pubmed/29371919
http://dx.doi.org/10.18632/oncotarget.21300

Ejemplares similares